Amgen and Cytokinetics announce the first presentation of data from Phase 2 ATOMIC-AHF study of Omecamtiv Mecarbil
First trial to evaluate cardiac myosin activator in patients with…
3 September 2013 | By Amgen
First trial to evaluate cardiac myosin activator in patients with acute heart failure presented at ESC Congress 2013...